Matthew Hammond

Director at DTx Pharma

Matthew Hammond joined RA Capital in 2014 and is currently a Principal on the Investment Team. Matthew works on both public and private investments and serves as a Director for Cerebral Therapeutics, Kira Pharmaceuticals, and Research Alliance Corp I. Matthew holds a BS in Environmental Health Science from the University of Georgia and both a PhD in Biomedical Science and an MBA with a concentration in Finance from the University of Connecticut. His graduate research investigated innate immune responses after intracerebral hemorrhage.